SynthesisFrontiers in oncology2024

Comparative efficacy and hematologic safety of different dosages of JAK inhibitors in the treatment of myelofibrosis: a network meta-analysis.

Ke Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.